The European Study Group on Cystic Tumours of the Pancreas Correspondence to The European Study Group on Cystic Tumours of the Pancreas, Pancreatic Surgery Unit, Division of Surgery, Department of ...

"Providing patients with more potential treatment options is especially vital as a growing number of experimental therapies for pancreatic cancer have become available," Velculescu says. "We want to ...

The primary endpoint was postoperative complications, which were assessed based on the Esophageal Cancer Complications Consensus ... received other neoadjuvant therapy or relevant antitumor therapy ...

To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery (PCS) among patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal ...

Nearly 30% of pancreatic ductal adenocarcinomas (PDACs) exhibit a marked overexpression of monocarboxylate transporter 1 (MCT1) offering a unique opportunity for therapy ... 7 significantly reduces ...

The approval was based on results from the phase 2 LITESPARK-015 trial. The US Food and Drug Administration (FDA) has approved Welireg (belzutifan) for the treatment of patients aged 12 years and ...

Amplia says it has reached the requisite level of ‘partial responders’ in its mid-stage pancreatic cancer study Immutep reports “remarkable” response rates in a German-based lung cancer trial Paradigm ...

The study evaluates the feasibility, safety, and tolerability of neoadjuvant radiotherapy followed by a CDK4/6 inhibitor (dalpiciclib) and hormonal therapy in treatment-naive patients with unilateral ...

1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

State Key Laboratory of Chemical Resource Engineering, MOE Key Lab of Biomedical Materials of Natural Macromolecules, Beijing University of Chemical Technology, Beijing 100029, China ...

The objectives are as follows: To assess the effectiveness and safety of total neoadjuvant therapy versus standard therapy in individuals with locally advanced rectal cancer. This is a protocol. Was ...